The PCI Center

Filter Your Results

 

News

 

Two-Year ADAPT-DES Data Examine Relationship of IVUS Guidance on DES Outcomes

November 16, 2018 -- Two-year follow-up data from the large-scale ADAPT-DES study assessing dual-antiplatelet therapy with drug-eluting stents (DESs) implanted with intravenou…

Cardiva Medical's Vascade MVP System Studied for Multivessel Closure After Electrophysiology Procedures

November 10, 2018 -- Cardiva Medical, Inc. announced that the Vascade MVP vascular closure system, which is designed specifically for multi-access venous closure after electro…

Preclinical Study Investigates Effect of DES Drug at Stent Fracture Sites

October 30, 2018 -- CBSET, a preclinical research institute dedicated to biomedical technologies, announced that its scientists have published “Fracture in drug-eluting …

British Study Analyzes Outcomes of CTO-PCI Procedures Using Enabling Strategies

October 30, 2018 -- Online in Circulation: Cardiovascular Interventions, Tim Kinnaird, MD, et al published findings from an analysis of 28,050 cases from the British Cardiovas…

Diagnosing Gray Zone Coronary Physiology

Moderator: William F. Fearon, MD
Panel: Morton J. Kern, MD, MSCAI, FAHA, FACC; Nils P. Johnson, MD, MS; and John McBarron Hodgson, MD, MSCAI

September/October 2018—CASE PRESENTATION A 50-year-old man with hypertension, dyslipidemia, and a family history of premature coronary disease presents to the catheterization laboratory with a 2-…

Complicated Radial Access During Primary PCI

Moderator: Pieter C. Smits, MD, PhD, FESC
Panel: Mohamed Abdel-Wahab, MD, FESC; Peter W. Danse, MD; and Valeria Paradies, MD

September/October 2018— CASE PRESENTATION An 85-year-old man with no cardiac history was diagnosed with a 3-hour-old acute inferior-posterior ST-segment elevation myocardial infarction (STEMI)…

Challenging Cases: What Would You Do?

Ted E. Feldman, MD, MSCAI, FACC, FESC; and Shakeel A. Qureshi, MD, FRCP, FRCPCH

September/October 2018— Most issues of Cardiac Interventions Today are focused on a single disease state. This issue takes a different approac

FDA Grants Breakthrough Device Designation for Neovasc's Reducer

October 10, 2018 -- Neovasc Inc. announced that the FDA has granted Breakthrough Device designation to the Neovasc Reducer, a device for the treatment of refractory angina tha…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.